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Objective:  There  is  a  scarcity  of  studies  that  assessed  the  association  between  adherence  to
combination  therapy  and  asthma  control  in  pediatric  patients.  The  authors  investigated  the
association  between  adherence  to  ﬂuticasone  propionate/salmeterol  xinafoate  combination-
metered  aerosol  and  the  level  of  asthma  control  in  children.
Methods:  This  was  a  prospective  observational  study  of  84  patients  aged  5--16  years  with  mod-
erate persistent  asthma,  who  remained  uncontrolled  despite  the  use  of  1000  g/day  of  inhaled
nonextraﬁne-hydroﬂuoric  alkane-beclomethasone  dipropionate  in  the  three  months  prior  to
study enrollment.  Participants  were  prescribed  two  daily  doses  of  FP  (125  g)/salmeterol
xinafoate  (25  g)  combination  by  metered  aerosol/spacer  for  six  months.  Adherence  rates  were
assessed using  the  device’s  dose  counter  after  the  2nd,  4th,  and  6th  months  of  follow  up.  Asthma
control was  assessed  using  a  simpliﬁed  Global  Initiative  for  Asthma  2014  Report  classiﬁcation. Please cite this article as: Jentzsch NS, Silva GC, Mendes GM, Brand PL, Camargos P. Treatment adherence and level of control in moderate
persistent asthma in children and adolescents treated with ﬂuticasone and salmeterol. J Pediatr (Rio J). 2019;95:69--75.
 The medications and spacers were provided free of charge through the Brazilian Uniﬁed Health System (SUS) of Belo Horizonte City
Hall.
∗ Corresponding author.
E-mails: nulma.jentzsch@cienciasmedicasmg.edu.br, nulmasj@gmail.com (N.S. Jentzsch).
https://doi.org/10.1016/j.jped.2017.10.008
0021-7557/© 2017 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Results:  Mean  adherence  rates  after  the  second,  fourth,  and  sixth  months  were  87.8%,  74.9%,
and 62.1%  respectively,  for  controlled  asthma,  and  71.7%,  56.0%,  and  47.6%  respectively,  for
uncontrolled  asthma  (all  p-values  ≤  0.03).  The  proportion  of  children  achieving  asthma  control
increased to  42.9%,  67.9%  and  89.3%  after  the  2nd,  4th  and  6th  months  of  follow-up,  respectively
(p ≤  0.001).
Conclusion:  Adherence  rates  between  87.8%  in  the  2nd  month  and  62.1%  in  the  6th  month  were
strong determinants  of  asthma  control.
© 2017  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open








Adesão  ao  tratamento  e  nível  de  controle  da  asma  persistente  moderada  em  crianc¸as
e  adolescentes  tratados  com  ﬂuticasona  e  salmeterol
Resumo
Objetivo:  São  escassos  os  estudos  que  avaliaram  a  relac¸ão  entre  a  taxa  de  adesão  à  combinac¸ão
de proprionato  de  ﬂuticasona/xinafoato  de  salmeterol  e  o  nível  de  controle  da  asma  na  infância.
O presente  estudo  teve  como  objetivo  avaliar  essa  relac¸ão.
Métodos:  Estudo  prospectivo  observacional  com  84  participantes,  de  5  a  16  anos,  todos  eles  com
asma persistente  moderada  que  permaneceram  não  controlados  apesar  do  uso  de  1.000  g/dia
de dipropionato  de  beclometasona  em  partículas  não  extraﬁnas  nos  três  meses  que  anteced-
eram a  admissão  no  estudo.  Os  participantes  receberam  prescric¸ão  de  125  g  de  propionato  de
ﬂuticasona e  25  g  xinafoato  de  salmeterol  através  de  inalador  pressurizado,  duas  vezes  ao  dia,
e foram  avaliados  após  o  2◦,  4◦ e  6◦ meses  de  tratamento.  A  taxa  de  adesão  foi  obtida  por  meio
do contador  analógico  de  doses  incorporado  ao  inalador.  A  classiﬁcac¸ão  do  nível  de  controle  da
asma foi  baseada  numa  simpliﬁcac¸ão  das  recomendac¸ões  da  Global  Initiative  for  Asthma.
Resultados:  As  taxas  de  adesão  aos  2,  4  e  6  meses  para  a  asma  controlada  foram  87,8%,  74,9%
e 62,1%  e  para  a  asma  não  controlada  de  71,7%,  56,0%  e  47,6%  (p  ≤  0,03),  respectivamente.
A proporc¸ão  de  pacientes  com  asma  controlada  elevou-  se  para  42,9%,  67,9%  e  89,3%  nas  três
avaliac¸ões subsequentes  (p  ≤  0,001).
Conclusões:  Taxas  de  adesão  entre  87,8%  no  2◦ mês  e  de  62,1%  no  6◦.  mês  foram  determinantes
para o  nível  de  controle  da  asma.
© 2017  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´ um  artigo







































he  ﬁrst-line  treatment  of  asthma  is  the  use  of  inhaled  cor-
icosteroids  (IC),  but  disease  control  is  not  always  attained
ith  the  use  of  these  drugs  alone.1
Adherence  to  a  given  therapeutic  regimen  is  the  process
y  which  the  patient  strictly  follows  a  regimen  of  care  and,
egarding  inhaled  medications,  the  most  accurate  and  reli-
ble  methods  of  evaluating  adherence  are  the  electronic  and
nalog  dose-counting  monitors.  Both  are  more  reliable  than
he  reports  by  patients  or  family  members,  clinical  judg-
ent,  drug  dispensing  by  the  pharmacy,  and  weighing  of
ose-counting  inhalers.2,3 Assessing  adherence  through  the
nalog  counter  in  the  pressurized  inhaler  is  similar  to  the
lectronic  method,  thus  allowing  the  obtaining  of  a  reli-
ble  adherence  rate.4 In  turn,  both  have  the  drawback  of
ntentional  emptying  of  the  pressurized  inhaler.5
Asthma  treatment  adherence  rates  are  generally  lower
han  prescribed,  and  studies  have  shown  that  a  low  adher-
nce  rate  is  one  of  the  most  common  causes  of  lack  of
linical  and  functional  disease  control.6 In  the  case  of  chil-
ren,  when  parents  have  a  negative  perception  of  asthma,
m
e
ehey  may  question  the  need  for  IC  use  at  the  same  time  as
hey  are  concerned  about  the  adverse  effects  of  medication.
oreover,  when  they  do  not  have  the  necessary  informa-
ion  to  understand  the  disease,  the  adherence  rate  may  be
ven  lower.7 Adherence  rates  greater  than  60%  are  associ-
ted  with  a  better  level  of  asthma  control.8 However,  great
ariability  can  be  found  in  studies  carried  out  in  the  last
wo  decades.  Bender,  for  instance,  reported  rates  of  19--58%
n  ten  studies  that  assessed  adherence  through  electronic
ose-counting,9 whereas  other  researchers  reported  a  vari-
tion  of  30%  to  70%.  Rates  of  less  than  50%  are  insufﬁcient  to
ontrol  the  disease  and,  consequently,  are  associated  with
 greater  frequency  of  disease  exacerbations,  hospitaliza-
ions,  and  the  need  for  emergency  care.10
In  turn,  it  is  known  that  a  clinical  response  to  the  isolated
se  of  IC  is  observed  only  after  the  ﬁrst  weeks  of  treat-
ent,  whereas  the  association  with  prolonged-action  beta-2
gonist  could  bring  faster  clinical  beneﬁts,  due  to  its  bron-
hodilator  action.  Studies  have  shown  that  this  association
ay  help  the  attainment  of  control  in  patients  with  mod-



















































bAdherence  and  asthma  control  
A  literature  search  in  the  Pubmed/MedLine,  Lilacs,  Sci-
elo,  Ebsco,  and  Cochrane  Collaboration  databases  including
the  past  15  years  identiﬁed  few  studies  that  assessed  the
adherence  rate  to  the  ﬂuticasone  propionate-salmeterol
xinafoate  association  and  the  level  of  asthma  control  in  chil-
dren  in  developing  countries.12 The  present  study  aimed
to  evaluate  the  association  between  asthma  treatment
adherence  and  control  rates  through  this  therapeutic  com-
bination.
Methods
Study  site  and  design
This  was  a  prospective  observational  study  with  a  six-month
follow-up,  for  which  patients  with  moderate  persistent
asthma  were  recruited  and  were  followed  at  a  secondary
pediatric  referral  service  linked  to  the  Municipal  Health  Sec-
retariat  of  the  city  of  Belo  Horizonte,  state  of  Minas  Gerais,
Brazil.  The  number  of  children  treated  at  that  service  during
the  period  covered  by  the  study  was  127.  All  84  children  who
met  the  inclusion  criteria  were  consecutively  admitted  and
completed  the  follow-up  period  predeﬁned  in  the  research
protocol.  Data  collection  lasted  one  year  and  three  months.
Inclusion  and  exclusion  criteria
Children  and  adolescents  aged  5--16  years  of  age,  with
moderate  persistent  asthma  without  clinical  control  at
admission  despite  adequate  adherence  (veriﬁed  through
medication  dispensing  at  the  pharmacy)  to  the  prescrip-
tion  of  1000  g/day  of  beclomethasone  dipropionate  with
hydroﬂuoroalkane  propellant  (hydroﬂuoric  alkane)  in  non-
extraﬁne  particles.  The  diagnosis  of  asthma  was  based  on
the  clinical  criteria  proposed  by  the  Global  Initiative  for
Asthma  (GINA).13 The  parents  or  guardians,  all  of  whom
were  literate,  signed  the  informed  consent  form  to  autho-
rize  the  participation  of  their  children  in  the  study;  those
older  than  12  years  also  signed  the  term  of  assent.  Children
and  adolescents  who  were  passive  smokers  and  those  with
comorbidities  were  excluded.
Asthma  control  level
As  the  main  objective  of  asthma  treatment  is  to  achieve
full  disease  control,  only  two  categories  were  adopted  on
the  two-,  four-,  and  six-month  follow-up  visits:  controlled
asthma  and  uncontrolled  asthma,  the  latter  encompassing
partially  and  totally  uncontrolled  disease  presentations,  in
accordance  with  the  GINA  classiﬁcation.13 Thus,  controlled
asthma  was  deﬁned  by  the  following  criteria:  (1)  absence  of
daytime  symptoms,  maintenance  of  normal  physical  activi-
ties,  absence  of  nocturnal  symptoms,  absence  of  nocturnal
arousal  with  symptoms,  no  need  to  use  rescue  medication,
and  no  exacerbation  in  the  four  weeks  preceding  the  two-
,  four-,  and  six-month  evaluations.  The  presence  of  one  of
the  above  criteria  was  considered  as  uncontrolled  asthma.
Spirometry,  albeit  not  part  of  the  GINA  control  criteria,13
leads  to  a  more  reliable  asthma  monitoring  and  was  per-






spirometer  (PDS  Instrumentation,  Colorado,  USA),
ulmonary  Function  Tests  (PFT)  version  4.12  used  was  and
he  reliability  and  reproducibility  criteria  recommended  by
he  American  Thoracic  Society  and  European  Respiratory
ociety  were  used,14 whereas  the  reference  values  used
ere  obtained  from  Polgar  and  Promadhat.15
herapeutic  regimen
ll  participants  received  the  medications  free  of  charge:
albutamol  for  treatment  of  exacerbations,  100ug/jet  Neb-
lizer  (Aerolin
®
-- GlaxoSmithKleine,  Brazil)  and  the  combi-
ation  of  125  /ﬂuticasone  propionate  and  25  /salmeterol
inafoate  jet  nebulizer  (Seretide
®
-- GlaxoSmithKleine,  SP,
razil),  the  latter  with  a  dose  counter,  prescribed  in  two
aily  doses  (morning  and  evening).  The  number  of  doses
onsumed  in  the  two  previous  months  corresponded  to  that
ecorded  by  the  counter  during  each  of  the  three  bimonthly
valuations  performed  during  follow-up.  A  large-volume
alve  spacer  (Flumax
®
--  Inside  Materiais  Avanc¸ados,  SP,
razil)  was  also  supplied.  All  children  used  the  same  type  of
pacer,  the  only  one  provided  free  of  charge,  regardless  of
ge.  This  conservative  measure  was  taken  due  to  the  lack  of
esources  by  the  participating  families,  which  often  lacked
ood  understanding  and  educational  level,  despite  the  fact
hat  parents  were  literate;  this  aimed  to  ensure  the  ade-
uate  quality  of  the  inhalation  technique,  a  crucial  condition
or  the  evaluation  of  both  adherence  and  level  of  disease
ontrol.  Regarding  the  guidelines  for  the  inhalation  route  in
ach  consultation,  the  following  parameters  were  observed:
pacer  hygiene,  agitation  of  the  pressurized  inhaler  before
se,  and  number  of  inspirations  after  each  nebulization.
dherence  rates
he  adherence  rate  was  expressed  by  calculating  the  per-
entage  of  the  number  of  used  doses  divided  by  the  number
f  prescribed  doses  ×100,  considering  the  day  of  medica-
ion  dispensation  (the  inhaler  contains  120  doses)  and  the
umber  of  remaining  doses  veriﬁed  on  the  date  of  the  three
ontrol  visits  (two,  four,  and  six  months  after  admission).
he  service  where  the  medication  was  dispensed  was  the
ame  where  the  study  was  carried  out.  The  expected  ade-
uate  adherence  was  100%.
tatistical  analysis
he  dependent  variable  was  the  asthma  control  level,
.e.,  adequate  control  or  lack  of  control.  The  independent
ariables  were  time  of  follow-up,  adherence  rate,  gender,
aternal  age  and  level  of  schooling,  and  mean  monthly
amily  income.  When  assessing  the  patients’  proﬁle  at  the
rst  consultation,  absolute  and  relative  frequencies  were
sed  for  the  categorical  variables,  whereas  the  means  and
tandard  deviations  were  used  for  the  quantitative  varia-
les.The  chi-squared  test  was  used  to  compare  the  group
f  patients  who  had  controlled  and  uncontrolled  asthma.
on-parametric  tests  were  used  to  compare  the  rate
f  adherence  among  participants  who  had  controlled
72  Jentzsch  NS  et  al.
Table  1  Characteristics  of  the  patients  in  each  group  at  the  ﬁrst  consultation  (2  months  of  treatment).
Characteristics  Uncontrolled  Controlled  p-Valuea
n  =  58 n  =  26
Child’s  gender Female  29  60.4%  18  56.0% 0.341
Male 19  39.6%  18  44.0%
Child’s age  (year) 5--6  27  56.2%  19  54.8% 0.752
Older than  6  21  43.8%  17  45.2%
Maternal  age
(years)
Up  to  30  24  50.0%  21  53.6% 0.449
Older than  30 24  50.0%  15  46.4%
Maternal  level  of
schooling  (years)
Up  to  8 36  75.0% 25  72.6% 0.572
More than  9 12  25.0% 11  27.4%
Family income >2  MW 15  31.2% 12  32.1% 0.840



































































DMWs, Brazilian minimum wages.
a Chi-squared test.
sthma  and  those  with  uncontrolled  asthma,  stratiﬁed  by
onsultation  (Mann--Whitney  test),  and  to  compare  the  rate
f  adherence  between  consultations,  stratiﬁed  by  controlled
nd  uncontrolled  asthma  (Kruskal--Wallis  test;  the  Nemenyi
est  was  used  for  multiple  comparisons).
Marginal  logistic  regression  was  used  to  verify  whether
he  independent  variables  had  an  inﬂuence  on  asthma  con-
rol  and,  for  this  purpose,  the  backward  method  was  used,
hich  is  the  procedure  of  consecutively  removing  the  varia-
les  with  greater  p-value;  this  procedure  is  repeated  until
nly  signiﬁcant  variables  remain  in  the  model.  A  conven-
ional  signiﬁcance  level  of  5%  was  used  for  the  backward
ethod.
The  generalized  estimating  equations  (GEEs)  method  was
sed  to  evaluate  the  individual  correlation  of  adherence
easurements  with  the  asthma  control  level.16
The  mean  rate  of  drug  adherence  was  compared  with  the
sthma  control  level  and  expressed  in  box-plot  charts  in  the
econd,  fourth,  and  sixth  months.  The  means  (and  respec-
ive  standard  deviation),  medians,  minimum  and  maximum
ariations,  and  ﬁrst  and  third  quartiles  of  the  adherence
ates  of  the  respective  months  were  also  calculated.  The
oxplot  is  adequate  to  represent  the  non-parametric  tests,
ince  it  provides  clinically  important  information,  such  as
he  medians  and  quartiles  of  each  group/time.  The  software
sed  in  the  analysis  was  R
®
version  3.0.3  (R  Foundation  for
tatistical  Computing,  Vienna,  Austria).
thical  aspects
he  study  protocol,  as  well  as  the  terms  of  consent  and
ssent,  were  approved  by  the  Research  Ethics  Committee
f  Faculdade  de  Ciências  Médicas  de  Minas  Gerais,  under
umber  0117.0.418.000-11.
esults
ighty-four  patients  were  recruited  for  the  study  with  the
ollowing  admission  characteristics:  the  mean  age  was  7.4
ears,  54.8%  of  them  were  aged  between  5  and  7  years,  with
 predominance  of  females  (56.0%).  The  mean  maternal  age
as  32.5  years,  of  whom  46.4%  were  older  than  30  years,
I
t
end  most  mothers  (72.6%)  reported  at  least  eight  years  of
lementary  school  education.  The  mean  monthly  family
ncome  was  R$  700.00  in  67.9%  of  the  families.
As  expected,  47  of  the  84  patients  (56.0%)  underwent
pirometry,  of  whom  38  were  children  older  than  6  years  and
ine  were  aged  5  years.  The  mean  initial  and  ﬁnal  forced
xpiratory  ﬂow  in  the  ﬁrst  second  (FEV1)  were  76.3%  and
0.3%  of  the  predicted  values,  respectively.
Table  1  shows  the  results  of  the  evaluation  of  the  second
onth  of  treatment;  no  statistical  difference  was  observed
etween  the  two  groups.
Table  2  shows  the  distribution  of  the  asthma  control
evel  according  to  the  adherence  rate  veriﬁed  in  the  three
imonthly  consultations.  It  was  observed  that  in  the  group
here  asthma  was  not  controlled,  the  mean  adherence  rates
n  the  second,  fourth,  and  sixth  months  were  71.7%,  56.0%,
nd  47.6%,  whereas  the  group  with  controlled  asthma  pre-
ented  signiﬁcantly  higher  rates,  87.8%,  74.9%,  and  62.1%,
espectively,  and  this  difference  was  statistically  signiﬁcant
p-value  =  0.002).
Table  3  shows  the  results  of  the  multivariate  analysis,
emonstrating  the  inﬂuence  of  time  of  treatment,  partici-
ant’s  gender  and  age,  maternal  age  and  level  of  schooling,
nd  monthly  family  income  on  the  level  of  asthma  control.
Adherence  rate,  gender,  and  maternal  level  of  schooling
ere  signiﬁcantly  associated  with  controlled  asthma.  Boys
ere  2.84  times  (95%  CI:  1.02--7.87)  more  likely  to  attain
sthma  control  than  girls,  and  each  additional  year  of  mater-
al  schooling  increased  the  likelihood  of  achieving  asthma
ontrol  by  1.19  times  (95%  CI:  0.99--1.42).
Fig.  1  shows  the  comparison  of  the  adherence  rate  in
he  second,  fourth,  and  sixth  months  of  treatment  and  the
evel  of  asthma  control.  Once  again,  higher  adherence  rates
ere  associated  with  a  better  level  of  disease  control.  A
onsistent  dose--response  gradient  was  observed  for  adher-
nce  rate  and  asthma  control  level  at  the  three  moments  of
he  clinical--functional  evaluation.
iscussionn  this  observational  study  carried  out  exclusively  in
he  pediatric  population,  it  was  observed  that  adher-
nce  greater  than  60%  led  to  better  control  of  moderate
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Table  2  Comparison  of  adherence  rates  between  groups  stratiﬁed  by  time  of  treatment.
Adherence  rate  n  (%)  Mean  (SD)  Min  1st  Q  Median  3rd  Q  Max.  p-Valuea
2  months
Uncontrolled  48  (57.1%) 71.7  (13.2)  42.9  62.8  70.6  80.0  98.4 0.000
Controlled  36  (42.9%)  87.8  (8.8)  64.5  80.5  89.6  95.2  98.4
4 months
Uncontrolled  27  (32.1%)  56.0  (8.7)  40.8  50.0  58.8  60.3  75.9 0.000
Controlled  57  (67.9%)  74.9  (11)  53.1  65.9  75.0  83.3  100
6 months
Uncontrolled  9  (10.7%)  47.6  (11.1)  33.9  37.3  49.2  52.6  67.4 0.002
Controlled  75  (89.3%)  62.1  (13.5)  42.0  53.1  59.4  66.7  100
SD, standard deviation; Q, quartile; Min., minimum; Max., maximum.
a Mann--Whitney test.
Table  3  Factors  associated  with  the  level  of  asthma  control.
Source  Backward  marginal  logistic  regression
p-Value  OR  95%  CI
Consultation  at  2  months  --  1  --
Consultation  at  4  months  0.000  31.16  [11.3;  85.93]
Consultation  at  6  months  0.000  794.9  [120.4;  5245.8]
Adherence rate  0.000  1.15  [1.11;  1.20]
Female gender  --  1  --
Male gender  0.045  2.84  [1.02;  7.87]
Maternal schooling  (years)  0.067  1.19  [0.99;  1.42]






















Figure  1  Rate  of  adherence  to  the  combination  of  ﬂuticasone





















dasthma control  in  the  three  evaluations  performed  during  the
follow-up  period.
persistent  asthma.  This  is  the  main  clinical  implication  of
the  present  results.
Studies  on  asthma  treatment  adherence  in  developing
countries  through  reliable  methods  such  as  dose  counters




mombination  therapy  (i.e.,  inhaled  corticosteroid  and  long-
cting  beta-agonist)  and  the  level  of  asthma  control  are
ven  rarer.  This  is  the  second  message  of  the  present  study,
hich  aimed  to  contribute  to  better  management  of  asthma
n  children.
The  factors  that  inﬂuenced  asthma  control  were  the
ecrease  in  the  adherence  rate  during  follow-up,  male  gen-
er,  and  maternal  level  of  schooling.  Studies  on  the  inﬂuence
f  gender  are  controversial,  but  the  decrease  in  adherence
ates  during  the  course  of  treatment  is  well  known  in  all
hronic  diseases,  such  as  asthma.16
The  inﬂuence  of  maternal  schooling  observed  in  the
resent  study  is  corroborated  by  a  study  carried  out  by
rrutia-Pereira  et  al.,  in  an  asthma  prevention  program  in
io  Grande  do  Sul,  where  35.6%  of  the  participating  moth-
rs  had  an  educational  level  of  less  than  eight  years  of
chooling.17
Bender  reports  that  there  has  been  little  change  in  the  IC
dherence  rate  in  the  last  25  years;  in  ten  studies  included
n  his  review,  the  lack  of  asthma  control  was  associated
ith  adherence  rates  ranging  from  19%  to  58%.  It  was  con-
luded  that  better  understanding  of  the  management  by  the
aregivers  and  use  of  the  correct  inhalation  technique  were
eterminant  for  better  disease  control.9
One  limitation  of  the  present  study  is  that  the  dose
ounter  coupled  to  the  inhaler  does  not  exclude  deliberate
mptying  of  medication.18 However,  Given  et  al.  demon-
trated  the  reliability  of  this  method.4 The  adherence  rate






















































uch  as  dose  counters,  to  differentiate  between  patients
dhering  to  the  therapeutic  regimen  and  those  who  do  not,
oth  in  clinical  practice  and  in  research.19--21
In  clinical  practice,  if  an  optimal  level  of  asthma  control
s  not  achieved,  the  treatment  adherence  rate,  among  other
actors,  should  be  veriﬁed  before  prescribing  a  higher  dose
f  IC,  combined  or  not  with  another  drug.
In  meta-analysis  of  ten  studies  that  aimed  to  measure
dherence  to  IC  treatment  through  electronic  monitors  in
ediatric  patients,22 individuals  who  experienced  exacer-
ations  had  a  mean  rate  of  isolated  IC  adherence  of  14%,
hereas  in  those  with  controlled  asthma,  the  mean  adher-
nce  rate  was  68%,  which  is  very  close  to  that  found  in  the
resent  study,  i.e.,  sufﬁcient  for  asthma  control.
Pedersen  et  al.  followed-up  19  children  aged  6--15  years
ith  moderate  and  severe  asthma  who  used  budesonide  for
our  weeks.  The  use  of  half  (i.e.,  100  mcg/day  of  budes-
nide)  of  the  prescribed  dose  --  assessed  by  weighing  the
nhalers  -- was  enough  to  control  the  symptoms.  The  very
hort  period  of  study  follow-up  is  noteworthy.23
Klok  et  al.,  in  a  review  of  14  studies  on  asthma  treat-
ent  adherence  using  an  electronic  monitor  in  children,
egardless  of  disease  severity,  found  a  time  of  follow-up
rom  13  weeks  to  18  months  and  variation  in  adherence  to  IC
reatment  of  34--92%;  in  the  research  that  lasted  six  months
similar  to  the  present  study)  an  adherence  rate  of  50%  was
bserved.24
The  ﬁnal  model  of  the  multivariate  analysis  showed  that
ale  gender,  maternal  schooling,  and  duration  of  follow-up
ere  associated  with  adequate  asthma  control.
The  present  study  has  further  clinical  implications  in
ddition  to  those  previously  mentioned.  The  results  sug-
est  that  both  the  rate  of  adherence  to  inhaled  medication
nd  the  level  of  asthma  control  should  be  systematically
eriﬁed  in  any  clinical  evaluation  of  the  asthmatic  patient,
hether  or  not  those  evaluations  were  programmed.  More-
ver,  they  indicate  that,  to  attain  clinical  and  functional
ontrol  of  moderate  persistent  asthma  in  children  and  ado-
escents  who  are  using  the  therapeutic  regimen  adopted  in
he  present  study,  the  rate  of  adherence  could,  in  fact,  be
ower  than  the  ideal  of  100%,  since  a  minimum  of  60%  adher-
nce  to  the  therapeutic  regimen  adopted  was  sufﬁcient  to
chieve  asthma  control.  These  adherence  rates  were  lower
han  those  reported  in  the  literature.1,24
onﬂicts of interest
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